Nutex Health (NASDAQ:NUTX) Stock Price Down 5.9% - What's Next?

Shares of Nutex Health Inc. (NASDAQ:NUTX - Get Free Report) traded down 5.9% during mid-day trading on Tuesday . The stock traded as low as $115.00 and last traded at $110.75. 53,381 shares changed hands during mid-day trading, a decline of 28% from the average session volume of 74,106 shares. The stock had previously closed at $117.66.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on NUTX. Maxim Group boosted their target price on shares of Nutex Health from $100.00 to $225.00 and gave the company a "buy" rating in a research note on Tuesday, May 20th. Wall Street Zen cut Nutex Health from a "strong-buy" rating to a "buy" rating in a research report on Thursday, May 22nd. Finally, Benchmark raised their target price on Nutex Health from $150.00 to $300.00 and gave the stock a "buy" rating in a research report on Thursday, May 15th.

Nutex Health Trading Down 2.5%

The company has a quick ratio of 1.74, a current ratio of 1.77 and a debt-to-equity ratio of 3.36. The firm has a market capitalization of $653.82 million, a PE ratio of -12.54 and a beta of 0.04. The stock's fifty day simple moving average is $135.38 and its 200 day simple moving average is $76.39.

Nutex Health (NASDAQ:NUTX - Get Free Report) last announced its quarterly earnings data on Tuesday, May 13th. The company reported $2.56 EPS for the quarter, beating the consensus estimate of ($0.15) by $2.71. Nutex Health had a negative return on equity of 51.27% and a negative net margin of 14.09%. The business had revenue of $211.79 million for the quarter, compared to the consensus estimate of $81.09 million.

Insider Buying and Selling

In other news, CFO Jon Christian Bates acquired 1,000 shares of the firm's stock in a transaction dated Tuesday, April 8th. The shares were acquired at an average cost of $81.81 per share, with a total value of $81,810.00. Following the acquisition, the chief financial officer now directly owns 4,888 shares of the company's stock, valued at approximately $399,887.28. The trade was a 25.72% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. 38.52% of the stock is owned by company insiders.

Institutional Investors Weigh In On Nutex Health

A number of hedge funds have recently bought and sold shares of the business. Bank of America Corp DE increased its stake in Nutex Health by 6,590.3% during the fourth quarter. Bank of America Corp DE now owns 2,074 shares of the company's stock worth $66,000 after acquiring an additional 2,043 shares during the last quarter. Northern Trust Corp bought a new stake in Nutex Health during the 4th quarter valued at $200,000. Millennium Management LLC purchased a new stake in shares of Nutex Health in the 4th quarter worth $213,000. World Investment Advisors bought a new position in shares of Nutex Health during the 4th quarter worth $217,000. Finally, OMERS ADMINISTRATION Corp bought a new stake in shares of Nutex Health in the fourth quarter valued at about $231,000. Hedge funds and other institutional investors own 5.32% of the company's stock.

Nutex Health Company Profile

Nutex Health Inc operates as a physician-led, healthcare services, and operations company. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The PHM segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management.